Brukamp K, et al. Nephrotic syndrome after hematopoietic cell transplantation: Do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol 2006; 1:685–694. doi: 10.2215/CJN.00380705.
Murphy WJ. Revisiting graft-versus-host disease models of autoimmunity: New insights in immune regulatory processes. J Clin Invest 2000; 106:745–747. doi: 10.1172/JCI11088
Hu SL. The role of graft-versus-host disease in haematopoietic cell transplantation-associated glomerular disease. Nephrol Dial Transplant 2011; 26:2025–2031. doi: 10.1093/ndt/gfq645.
Beck LH Jr, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11–21. doi: 10.1056/NEJMoa0810457
Tomas NM, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014; 371:2277–2287. doi: 10.1056/NEJMoa1409354
Sethi S, et al. Hematopoietic stem cell transplant-membranous nephropathy is associated with protocadherin FAT1. J Am Soc Nephrol [published online ahead of print March 23, 2022]. doi: 10.1681/ASN.2021111488; https://jasn.asnjournals.org/content/early/2022/03/23/ASN.2021111488
Kudose S, et al. NELL1-associated membranous glomerulopathy after hematopoietic stem cell transplantation. Kidney Int Rep 2021; 6:1992–1995. doi: 10.1016/j.ekir.2021.04.033.
Nasr SH, et al. Membranous nephropathy with extensive tubular basement membrane deposits following allogeneic hematopoietic cell transplant: A report of 5 cases. Am J Kidney Dis [published online ahead of print September 8, 2021]. doi: 10.1053/j.ajkd.2021.07.021; https://www.ajkd.org/article/S0272-6386(21)00840-4/fulltext
Hingorani S. Renal complications of hematopoietic-cell transplantation. N Engl J Med 2016; 374:2256–2267. doi: 10.1056/NEJMra1404711
Zeiser R, Blazar BR. Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med 2017; 377:2565–2579. doi: 10.1056/NEJMra1703472
Mattei D, et al. Long-term results of rituximab treatment for membranous nephropathy after allogeneic hematopoietic SCT: A case report. Bone Marrow Transplant 2010; 45:1111–1112. doi: 10.1038/bmt.2009.276
Jodele S, et al. Complement blockade for TA-TMA: Lessons learned from a large pediatric cohort treated with eculizumab. Blood 2020; 135:1049–1057. doi: 10.1182/blood.2019004218